Cross-sectional bibliometric study reveals significant pandemic-driven h-index inflation among productive health researchers, highlighting the need for cautious metric interpretation.
COVID-19-related research redistributed citations toward pandemic topics, but the author-level contribution of this redistribution to individual h-index values remains insufficiently documented in lower-volume national research systems. This cross-sectional bibliometric study used OpenAlex metadata from 2015–2025 to evaluate highly productive Peruvian health researchers. We assembled a non-random upper-productivity cohort of 500 authors; the primary cohort included 456 authors with fractional Peruvian affiliation of 0.5 or higher. Observed h-index values were compared with COVID-19-excluded h-index values recalculated after removing COVID-19-related works identified through an audited classifier. In the primary cohort, the median observed h-index was 12.0, the median COVID-19-excluded h-index was 11.0, and median Delta h was 0.00 [0.00, 1.25]. Overall, 210 authors (46.1%) had Delta h > 0; the observed total Delta h after COVID-19 removal was 450. A matched non-COVID removal benchmark produced a lower median simulated total Delta h of 297 [292, 303], and none of the 500 simulations reached the observed COVID-removal total. The proportional h-index change was larger among authors with lower baseline h-index, although this indicator is denominator-sensitive. COVID-19-related works had higher two-year citation velocity than non-COVID-19 works within the same authors. These findings support a cautious interpretation of h-index values from the pandemic period according to the thematic and temporal composition of the works contributing to the index.
No takes yet. Share an insight, caveat, or question.
Ponce et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: